WOONSOCKET, RI, February 24, 2021 / PRNewswire / – CVS Health (NYSE: CVS) added Alabama, Arizona, Florida, Louisiana, Ohio, and Pennsylvania to the list of states where selected CVS pharmacies will offer COVID-19 vaccines to eligible populations through the Federal Retail Pharmacy Program. This follows the success February 12th implementation in 11 states: California, Connecticut, Hawaii, Maryland, Massachusetts, New Jersey, New York, Rhode Island, South Carolina, Texas, and Virginia. Schedules for the last allocation of approximately 570,000 doses will begin to be made available for reservation today, with doses starting February 25.
“The feedback on all aspects of the vaccination process has been incredibly positive, from the digital experience to the interaction with our team of health professionals,” he said. Karen S. Lynch, President and CEO, CVS Health. “We are also making significant progress towards reaching vulnerable communities, which will continue to be an essential part of our vaccination effort.”
There are almost 10,000 CVS pharmacies across the country, with almost half located in communities with a high or very high rating on the Social Vulnerability Index (SVI) of the Centers for Disease Control and Prevention. The high SVI classification, together with the population density and demographics of the area, are critical factors in determining which CVS Pharmacy locations will offer COVID-19 vaccines. CVS Health recently announced several measures to address vaccine education and equity, particularly among black and Hispanic populations.
CVS Health has been offering COVID-19 vaccines to a limited extent in Ohio using state allocations. As more supplies become available through the federal program, the company will expand to other states and, at the same time, increase the number of stores offering vaccines. Pharmacy CVS has the capacity to administer 20 to 25 million injections per month.
Vaccines in a retail environment are only offered by appointment via CVS.com or through the CVS Pharmacy app, and those without online access can contact customer service: (800) 746-7287.
Long-term care vaccination effort nearly complete
CVS Health administered approximately four million doses of the COVID-19 vaccine to residents and employees at more than 40,000 long-term care facilities across the country through the Pharmacy Long-Term Care Partnership Program. CVS pharmacy staff completed second doses in all qualified nursing facilities and will complete second doses in nursing homes and other facilities in mid-March,[1] fulfilling the company’s commitment to help protect a population disproportionately affected by the pandemic. CVS Health has regularly updated its progress using publicly available data.
Multimedia features, including b-roll and photos of long-term care facilities and COVID-19 vaccines in stores, are available here. More information about the measures taken by CVS Health to deal with the pandemic is available at the company’s updated COVID-19 resource center.
About CVS Health
CVS Health is a different type of healthcare company. We are a diverse healthcare services company, with nearly 300,000 employees united around a common purpose to help people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing the healthcare system to meet their needs. Built on an unrivaled presence in the community, our diverse model involves one in three Americans each year. From our new innovative services at HealthHUB® locations to transformative programs that help manage chronic conditions, we are making healthcare more accessible, cheaper and simply better. Find out more about how we are transforming health at www.cvshealth.com.
Cautionary statement about forward-looking statements
The Private Securities Litigation Reform Act of 1995 provides a safe haven for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and / or quantify. Actual results may differ materially from those contemplated in the forward-looking statements due to the risks and uncertainties described in our Securities and Exchange Commission (“SEC”) files, including those set forth in the Risk Factors section and under the heading “Warning on Forward-Looking Statements” in our Annual Report most recently filed on Form 10-K and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2020. You are cautioned not to place undue reliance on CVS Health’s forward-looking statements. CVS Health’s forward-looking statements are and will be based on management’s current views and assumptions about future events and operating performance, and are applicable only on the dates of such statements. CVS Health does not undertake any obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or others.
Media contact
TJ Crawford
212-457-0583
[email protected]
1 Excludes facilities that 1) requested a later date due to a COVID-19 outbreak or another reason, 2) were rescheduled due to a lack of responsiveness, or 3) requested to be added to the program after the start date or did not meet the criteria for distance from CVS Pharmacy locations, but CVS Health chose to support it.
SOURCE CVS Health
Related Links
http://www.cvshealth.com